Literature DB >> 25274241

Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis.

Toshiki Nakajima1, Daisuke Kawabata, Shuichiro Nakabo, Aya Miyagawa-Hayashino, Naoichiro Yukawa, Hajime Yoshifuji, Koichiro Ohmura, Takao Fujii, Tsuneyo Mimori.   

Abstract

A 75-year-old woman with rheumatoid arthritis (RA) presented with long-term painful erythema on the right upper arm and left elbow. The patient was diagnosed with intralymphatic histiocytosis (ILH) based on the biopsy findings. Because the patient was unresponsive to single-agent treatment with methotrexate, infliximab and etanercept, we switched to tocilizumab (TCZ) treatment, which induced remission of the ILH. Our case suggests that TCZ may be a treatment option for ILH in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274241     DOI: 10.2169/internalmedicine.53.2688

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Two rare cases of laryngeal intralymphatic histiocytosis.

Authors:  Martin Reznitsky; Søren Daugaard; Birgitte Wittenborg Charabi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-14       Impact factor: 2.503

2.  Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis.

Authors:  Songsong Li; Zhenzhou Wu; Ling Li; Xuehua Liu
Journal:  Med Sci Monit       Date:  2016-06-20

3.  Intralymphatic Histiocytosis with Massive Interstitial Granulomatous Foci in a Patient with Rheumatoid Arthritis.

Authors:  Mayuri Tanaka; Yoko Funasaka; Kyoko Tsuruta; Akiko Kanzaki; Kenji Takahashi; Hidehisa Saeki
Journal:  Ann Dermatol       Date:  2017-03-24       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.